RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

A collection of news and information related to Food and Drug Administration published by this site and its partners.

Top Food and Drug Administration Articles

Displaying items 78-88
  • U.S. trade deal might loosen Europe's chemical safety rules

    WASHINGTON It has been difficult for American chemical companies to crack the European market because the safety standards there are tougher than they are in the U.S. But that might be changing. A pending free trade deal with the European Union, known as...
  • Report: Colgate Total toothpaste ingredient linked to cancer

    Report: Colgate Total toothpaste ingredient linked to cancer
    A chemical ingredient in a popular toothpaste brand has been linked to cancer-cell growth and disrupted development in animals, Bloomberg reports.  The chemical triclosan can be found in Colgate Total, a top selling toothpaste brand from Colgate-...
  • 'Bionic eye' maker Second Sight of Sylmar files for IPO

    'Bionic eye' maker Second Sight of Sylmar files for IPO
    "Bionic eye" manufacturer Second Sight Medical Products Inc. wants to offer its stock to the public. The Sylmar company makes a prosthetic retina that improves vision for patients with a rare disease called retinitis pigmentosa. It filed for an...
  • What is the FDA smoking?

    How much does the health benefit of giving up cigarettes outweigh the lost pleasure of smoking? Last spring, the Food and Drug Administration proposed rules to control e-cigarettes along with tobacco products. Under federal law, the FDA is required to...
  • Ban on gay blood donors is a civil rights issue, activists say

    Ban on gay blood donors is a civil rights issue, activists say
    When Ryan James Yezak's workplace hosted a blood drive a few years back, he told his boss he would be happy to donate. Then the West Hollywood resident found out that as a gay man, he was banned for life from giving blood under a federal regulation...
  • Prescription drug abuse is a complicated problem that ruins lives and careers [Letter]

    Prescription drug abuse is a complicated problem that ruins lives and careers [Letter]
    We were saddened to read about Baltimore County Police Officer Joseph Stanley Harden's arrest on robbery and drug possession charges ("Off-duty officer tries to break into home in search of drugs, police say," Aug. 1). The veteran officer reportedly...
  • Racism, the misuse of genetics and a huge scientific protest

    "A Troublesome Inheritance: Genes, Race, and Human History" is the new book by science writer Nicholas Wade that asserts a genetic basis for certain human behaviors and distinguishes them by race. It's been widely panned in book reviews, especially by...
  • 2 Liberian doctors to get experimental Ebola drug

    Liberia said on Tuesday it would treat two infected doctors with the scarce experimental Ebola drug ZMapp, the first Africans to receive the treatment, while authorities in Spain said a 75-year-old priest had died of the disease. The death toll from the...
  • Spanish priest becomes first Ebola patient to die in Europe

    MONROVIA, Liberia A Spanish priest who contracted Ebola in Liberia has died in a Madrid hospital, medical sources said on Tuesday, as the outbreak spreads through West Africa. Miguel Pajares, 75, was the first Ebola patient to die in Europe. He had...
  • The responsibility part of corporate 'personhood'

    The following editorial appeared in the Columbus Ledger-Enquirer on Sunday, Aug. 10: An ongoing trial in Georgia might or might not set any legal precedents, but it very well might be making a kind of history. In Albany, three officials of the now-...
  • Sanofi wins right to market MannKind's inhaled insulin drug Afrezza

    A French pharmaceutical company has agreed to pay up to $925 million for the right to market Afrezza, the recently approved inhaled insulin treatment for diabetes developed by MannKind Corp. of Valencia. Sanofi, based in Paris, said it would pay $150...